Advisory Committee to the Director (ACD), Centers for Disease Control and Prevention-State, Tribal, Local and Territorial (STLT) Subcommittee, 66938-66939 [2013-26632]
Download as PDF
<![CDATA[
66938
Federal Register / Vol. 78, No. 216 / Thursday, November 7, 2013 / Notices
(404)498–2506. The Director, Management
Analysis and Services Office, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for both
the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Catherine Ramadei,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
Catherine Ramadei,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention
tkelley on DSK3SPTVN1PROD with NOTICES
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
Board of Scientific Counselors, Office
of Public Health Preparedness and
Response, Board of Scientific
Counselors (BSC OPHPR)
Notice of Cancellation: This notice
concerns ‘‘Capacity Assistance for High
Impact HIV Prevention’’, Funding
Opportunity Announcement PS14–
1403, initial review, published in the
Federal Register on September 18, 2013
(FR Volume 78, Number 181, Page
57391). This SEP, scheduled to convene
on November 12–15, 2013, is canceled.
Notice will be provided if the meeting
is rescheduled in accordance with
section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92–463).
This notice is published less than the
required 15 days prior to the start of the
announced meeting, in accordance with
Section 102–3.150(b) of the GSA Final
Rule (2001) that allows for exceptions to
the meeting notification time
requirement. Section 102–3.150(b) states
the following: ‘‘In exceptional
circumstances, the agency or an
independent Presidential advisory
committee may give less than 15
calendar days’ notice, provided that the
reasons for doing so are included in the
advisory committee meeting notice
published in the Federal Register.’’
In this case, the agency is giving less
than 15 days’ notice due to the recent
furlough status of United States Federal
Government, including the U.S.
Department of Health and Human
Services, Centers for Disease Control
and Prevention, from October 1–16,
2013.
Contact Person for More Information:
Harriette A. Lynch, Public Health
Analyst, CDC, 1600 Clifton Road NE.,
Mailstop E07, Atlanta, Georgia 30333,
Telephone: (404) 718–8837. The
Director, Management Analysis and
Services Office, has been delegated the
Cancellation
This notice was published in the
Federal Register on September 12, 2013,
Volume 78, Number 177, page 56235.
The meeting previously scheduled to
convene on October 16–17, 2013, was
cancelled.
Contact Person for More Information:
Marquita Black, Executive Assistant,
Office of Science and Public Health
Practice, Centers for Disease Control and
Prevention, 1600 Clifton Road, NE.,
Mailstop D–44, Atlanta, Georgia 30333,
Telephone: (404) 639–7325; Facsimile:
(404) 639–7977; Email:
OPHPR.BSC.Questions@cdc.gov.
This notice is published less than the
required 15 days prior to the start of the
announced meeting, in accordance with
Section 102–3.150(b) of the GSA Final
Rule (2001) that allows for exceptions to
the meeting notification time
requirement. Section 102–3.150(b) states
the following: ‘‘In exceptional
circumstances, the agency or an
independent Presidential advisory
committee may give less than 15
calendar days’ notice, provided that the
reasons for doing so are included in the
advisory committee meeting notice
published in the Federal Register.’’
In this case, the agency is giving less
than 15 days’ notice due to the recent
furlough status of United States Federal
Government, including the U.S.
Department of Health and Human
Services, Centers for Disease Control
and Prevention, from October 1–16,
2013.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
Jkt 232001
[FR Doc. 2013–26634 Filed 11–6–13; 8:45 am]
BILLING CODE 4163–18–P
BILLING CODE 4163–18–P
BILLING CODE 4163–18–P
16:24 Nov 06, 2013
Catherine Ramadei,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2013–26651 Filed 11–6–13; 8:45 am]
[FR Doc. 2013–26636 Filed 11–6–13; 8:45 am]
VerDate Mar<15>2010
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Committee to the Director
(ACD), Centers for Disease Control and
Prevention—State, Tribal, Local and
Territorial (STLT) Subcommittee
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting of the
aforementioned subcommittee:
Time and Date: 3:00 p.m.–4:10 p.m. EST,
December 2, 2013.
Place: This meeting will be held by
teleconference.
Status: This meeting is open to the public,
limited only by the availability of telephone
ports (100). The public is welcome to
participate during the public comment
period, which is tentatively scheduled from
4:00 p.m. to 4:05 p.m. To participate on the
teleconference, please dial (888) 233–0592
and enter code 33288611.
Purpose: The Subcommittee will provide
advice to the CDC Director through the ACD
on strategies and future needs and challenges
faced by State, Tribal, Local and Territorial
health agencies, and will provide guidance
on opportunities for CDC.
Matters To Be Discussed: The STLT
Subcommittee members will discuss
implementation of ACD-adopted
recommendations related to the health
department of the future and how CDC can
best support STLT health departments.
The agenda is subject to change as
priorities dictate.
Contact Person for More Information: Judy
Monroe, M.D., Designated Federal Officer,
STLT Territorial Subcommittee, ACD, CDC,
1600 Clifton Road, NE., M/S E–70, Atlanta,
Georgia 30333. Telephone (404) 498–6775,
Email: OSTLTSDirector@cdc.gov. Please
submit comments to OSTLTSDirector@
cdc.gov by November 25, 2013.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
E:\FR\FM\07NON1.SGM
07NON1
66939
Federal Register / Vol. 78, No. 216 / Thursday, November 7, 2013 / Notices
Prevention and the Agency for Toxic
Substances and Disease Registry.
changed to Child Abuse Prevention
Program).
OMB No.: 0970–0155.
Description: The Program Instruction,
prepared in response to the enactment
of the Community-Based Grants for the
Prevention of Child Abuse and Neglect
(administratively known as the
Community Based Child Abuse
Prevention Program, (CBCAP), as set
forth in Title II of Public Law 108–36,
Child Abuse Prevention and Treatment
Act Amendments of 2003, and in the
process of reauthorization, provides
direction to the States and Territories to
accomplish the purposes of (1)
supporting community-based efforts to
develop, operate, expand, and where
appropriate to network, initiatives
aimed at the prevention of child abuse
and neglect, and to support networks of
Catherine Ramadei,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention (CDC).
[FR Doc. 2013–26632 Filed 11–6–13; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Proposed Information Collection
Activity; Comment Request
Proposed Projects
Title: Community-Based Family
Resource and Support Grants (Name
coordinated resources and activities to
better strengthen and support families to
reduce the likelihood of child abuse and
neglect, and; (2) fostering an
understanding, appreciation, and
knowledge of diverse populations in
order to be effective in preventing and
treating child abuse and neglect. This
Program Instruction contains
information collection requirements that
are found in (Pub. L. 108–36) at sections
201; 202; 203; 205; 206; 207; and
pursuant to receiving a grant award. The
information submitted will be used by
the agency to ensure compliance with
the statute, complete the calculation of
the grant award entitlement, and
provide training and technical
assistance to the grantee.
Respondents: State Governments.
ANNUAL BURDEN ESTIMATES
Number of
respondents
Instrument
tkelley on DSK3SPTVN1PROD with NOTICES
Application .......................................................................................................
Annual Report ..................................................................................................
Estimated Total Annual Burden
Hours: 3,328.
In compliance with the requirements
of Section 506(c)(2)(A) of the Paperwork
Reduction Act of 1995, the
Administration for Children and
Families is soliciting public comment
on the specific aspects of the
information collection described above.
Copies of the proposed collection of
information can be obtained and
comments may be forwarded by writing
to the Administration for Children and
Families, Office of Planning, Research
and Evaluation, 370 L’Enfant
Promenade SW., Washington, DC 20447,
Attn: ACF Reports Clearance Officer.
Email address:
infocollection@acf.hhs.gov. All requests
should be identified by the title of the
information collection.
The Department specifically requests
comments on: (a) Whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
the quality, utility, and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques or
VerDate Mar<15>2010
16:24 Nov 06, 2013
Jkt 232001
52
52
other forms of information technology.
Consideration will be given to
comments and suggestions submitted
within 60 days of this publication.
Robert Sargis,
Reports Clearance Officer.
[FR Doc. 2013–26672 Filed 11–6–13; 8:45 am]
BILLING CODE 4184–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2013–D–0575]
Agency Information Collection
Activities; Submission for Office of
Management and Budget Review;
Comment Request; Guidance for
Industry on Expedited Programs for
Serious Conditions—Drugs and
Biologics
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is announcing
that a proposed collection of
information has been submitted to the
Office of Management and Budget
(OMB) for review and clearance under
the Paperwork Reduction Act of 1995.
SUMMARY:
PO 00000
Frm 00050
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
1
1
Average
burden hours
per response
40
24
Total burden
hours
2,080
1,248
Fax written comments on the
collection of information by December
9, 2013.
ADDRESSES: To ensure that comments on
the information collection are received,
OMB recommends that written
comments be faxed to the Office of
Information and Regulatory Affairs,
OMB, Attn: FDA Desk Officer, FAX:
202–395–7285, or emailed to oira_
submission@omb.eop.gov. All
comments should be identified with the
OMB control number 0910—New and
title ‘‘Guidance for Industry on
Expedited Programs for Serious
Conditions—Drugs and Biologics.’’ Also
include the FDA docket number found
in brackets in the heading of this
document.
FOR FURTHER INFORMATION CONTACT: FDA
PRA Staff, Office of Operations, Food
and Drug Administration, 1350 Piccard
Dr., PI50–400B, Rockville, MD 20850,
PRAStaff@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: In
compliance with 44 U.S.C. 3507, FDA
has submitted the following proposed
collection of information to OMB for
review and clearance.
DATES:
Guidance for Industry on Expedited
Programs for Serious Conditions—
Drugs and Biologics—(OMB Control
Number 0910–New)
Description of Respondents:
Respondents to this collection of
E:\FR\FM\07NON1.SGM
07NON1
]]>Agencies
[Federal Register Volume 78, Number 216 (Thursday, November 7, 2013)]
[Notices]
[Pages 66938-66939]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-26632]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Committee to the Director (ACD), Centers for Disease
Control and Prevention--State, Tribal, Local and Territorial (STLT)
Subcommittee
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following meeting of the aforementioned
subcommittee:
Time and Date: 3:00 p.m.-4:10 p.m. EST, December 2, 2013.
Place: This meeting will be held by teleconference.
Status: This meeting is open to the public, limited only by the
availability of telephone ports (100). The public is welcome to
participate during the public comment period, which is tentatively
scheduled from 4:00 p.m. to 4:05 p.m. To participate on the
teleconference, please dial (888) 233-0592 and enter code 33288611.
Purpose: The Subcommittee will provide advice to the CDC
Director through the ACD on strategies and future needs and
challenges faced by State, Tribal, Local and Territorial health
agencies, and will provide guidance on opportunities for CDC.
Matters To Be Discussed: The STLT Subcommittee members will
discuss implementation of ACD-adopted recommendations related to the
health department of the future and how CDC can best support STLT
health departments.
The agenda is subject to change as priorities dictate.
Contact Person for More Information: Judy Monroe, M.D.,
Designated Federal Officer, STLT Territorial Subcommittee, ACD, CDC,
1600 Clifton Road, NE., M/S E-70, Atlanta, Georgia 30333. Telephone
(404) 498-6775, Email: OSTLTSDirector@cdc.gov. Please submit
comments to OSTLTSDirector@cdc.gov by November 25, 2013.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and
[[Page 66939]]
Prevention and the Agency for Toxic Substances and Disease Registry.
Catherine Ramadei,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention (CDC).
[FR Doc. 2013-26632 Filed 11-6-13; 8:45 am]
BILLING CODE 4163-18-P
